NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

Aurobindo Pharma today said it has received final approval from the US health regulator to manufacture and market generic version of heartburn relief medicine Famotidine tablets. The approval by the US Food and Drug Administration (USFDA) is for strengths of 10 mg and 20 mg, the company said in a…

news

British drugmaker AstraZeneca Plc said on Tuesday Ironwood Pharmaceuticals Inc (IRWD.O) would buy the U.S. marketing rights for its newly approved gout drug for up to $265 million. The deal gives Ironwood the rights to sell the drug, Zurampic, or lesinurad, which was approved in the United States last year…

news

Glenmark Pharmaceuticals rose 0.54% to Rs 836 at 10:05 IST on BSE after the company received tentative approval from the USFDA for a drug, which is a generic version of Lo Loestrin Fe Tablets. The announcement was made before market hours today, 25 April 2016. Meanwhile, the BSE Sensex was…

news

Sun Pharma yesterday signed a public-private-partnership (PPP) agreement with Indian Council of Medical Research (ICMR) for Malaria Free India initiative and other innovation in preventive health. The PPP stakeholders will jointly undertake malaria control & elimination programme by setting-up management & technical committees to provide oversight for disease surveillance &…

news

Embattled drugmaker Valeant Pharmaceuticals has chosen Perrigo Co. Chairman and CEO Joseph C. Papa to become its new CEO, replacing J. Michael Pearson. Valeant said Monday that the 60-year-old executive will start early next month and also join the company's board. Papa has served as Perrigo Co. Plc CEO since…

news

Aurobindo Pharma today said it has received final approval from the US health regulator to manufacture and market generic version of blood pressure treatment drugs Amlodipine and Valsartan tablets. The approval by the US Food and Drug Administration (USFDA) is for multiple strengths of 5mg/160mg, 5mg/320mg and 10mg/320 mg, the…

news

The Indian government and the drug industry are headed for yet another collision course after the acrimonious legal tussle over the approval of hundreds of drugs based on fixed dose combinations. Indian drug companies may seek legal intervention against the recent decision of the National Pharmaceutical Pricing Authority (NPPA) to…

Monday, Apr 25, 2016
news

Switzerland’s Novartis said this past week that it was seeing faster uptake of heart-failure drug Entresto in Europe than in the U.S. The potential blockbuster has struggled: It sold just $17 million in the first quarter, with Novartis guiding to $200 million for the year, well below forecasts. With heightened…

news

The German government is considering limiting the price that drug companies can charge the country’s health care system for their latest medicines—a move that would curtail a lucrative, one-year amnesty from the country’s otherwise strict price controls. Germany enjoys one of the world’s most generous universal health-insurance systems. Used by…

news

Mumbai-based active pharmaceutical ingredient (API) maker Anuh Pharma Ltd on Thursday said the World Health Organization (WHO) has suspended the prequalification of two of its APIs. “In view of the EDQM (European Directorate for the Quality of Medicines and Healthcare) suspension, the WHO prequalification authorities have suspended pyrazinamide and sulfadoxine…